Maria Sharapova’s Drug Manufacturer Says Treatment Not Normal
Russian tennis star Maria Sharapova’s 10-year prescription of the drug meldonium which cost her a failed drugs test is not normal. Meldonium’s normal course of treatment is four to six weeks according to its Latvian manufacturer and is meant for people with chronic cardiovascular problems. Sports Fan reports: The five-time Grand Slam champion said on Monday she failed a doping test at the Australian Open in January for meldonium, which became a banned substance under the World Anti-Doping Agency code this year.